Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Net Preferred Shares Issued and Repurchased (2024 - 2025)

Updated

Odyssey Therapeutics' Net Preferred Shares Issued and Repurchased was $2.98 million in Q4 2025, down 60.1% from $7.47 million a year earlier and down 96.7% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Net Preferred Shares Issued and Repurchased (2024 - 2025) Analysis & Trends

For FY2025, Net Preferred Shares Issued and Repurchased at Odyssey Therapeutics came in at $212.46 million, up 673.2% from FY2024.

  • Net Preferred Shares Issued and Repurchased shows a three-year compound annual growth rate of 6.1% (FY2022 to FY2025).
  • In earlier years, Net Preferred Shares Issued and Repurchased was $27.48 million in FY2024 (-71.5%), $96.57 million in FY2023 (-45.7%) and $177.77 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.98 Mn
Sep 30, 2025 90.73 Mn
Dec 31, 2024 7.47 Mn
API Access

Odyssey Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ODTX&period=max&api_key=YOUR_API_KEY